Lp(a) Testing in Latin America: Low Awareness and Clinicalpractice Among Medical Society Physicians Highlight a Missed Opportunity in Cardiovascular Prevention

Abstract Background and aims In Latin America (LATAM), the level of awareness and clinical implementation of lipoprotein(a) (Lp(a)) testing among physicians remain largely unknown. This study aimed to evaluate the knowledge, frequency of use, and clinical management practices related to Lp(a) among...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Ivette Cruz-Bautista, Yuscely Flores-Jurado, Antonio Barajas-Martínez, Yulino Castillo-Núñez, Daniel Elías-López, María Alejandra Ramos-Guifarro, Ramon Barrera-Cruz, Lizbeth Ruilova-González, Misael Aguilar-Panduro, Liliana Muñoz-Hernández, Roopa Mehta, Raquel N. Faradji, Eduardo Márquez-Rodríguez, Juan Carlos Garnica-Cuellar, Samantha Gutiérrez-Morales, José de Jesús Garduño-García, José Alberto Ávila-Funes, Arturo Guerra-López, Alejo Diaz-Aragón, Edith Ruiz-Gastelum, Jorge Cossio-Aranda, Raúl Velasco-Solorzano, Pablo Corral, Carlos O. Mendívil, Juan Patricio Nogueira, Mario Morales-Esponda, Carlos Alberto Aguilar -Salinas, Grupo Lípidos SMNE
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	BMC 2025-12-01
Reeks:	BMC Cardiovascular Disorders
Onderwerpen:	Lipoprotein(a) awareness Latin american physicians Barriers Survey Cardiovascular risk assessment Medical societies
Online toegang:	https://doi.org/10.1186/s12872-025-05461-6
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!